DekaBank Deutsche Girozentrale’s Cogent Biosciences COGT Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-85,000	Closed	-$833K	–	1483
2023 Q3	$833K	Hold	85,000	–	–	﹤0.01%	914
2023 Q2	$983K	Buy	85,000 +50,000	+143%	+$574K	﹤0.01%	884
2023 Q1	$365K	Hold	35,000	–	–	﹤0.01%	1082
2022 Q4	$402K	Buy	+35,000	New	+$434K	﹤0.01%	1084

Other funds holding COGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DekaBank Deutsche Girozentrale's COGT Position: Q4 2023 in Review

DekaBank Deutsche Girozentrale sold out of Cogent Biosciences (COGT) in Q4 2023, closing a stake of 85,000 shares — an estimated $833K sold.

DekaBank Deutsche Girozentrale first reported a position in COGT in Q4 2022 and held it in 4 quarters. The position peaked at $983K in Q2 2023. 144 funds tracked by Wall St. Rank hold COGT as of Q4 2023.

DekaBank Deutsche Girozentrale reported no remaining Cogent Biosciences position as of Q4 2023 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 85,000 Cogent Biosciences shares in Q4 2023, an estimated $833K.
DekaBank Deutsche Girozentrale first reported a position in Cogent Biosciences in Q4 2022 and held it in 4 quarters.
DekaBank Deutsche Girozentrale's Cogent Biosciences position peaked at $983K in Q2 2023.
144 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2023, filed 24 Jan 2024.